This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business equity admission

ProVen VCTs admit new shares

Analysis based on 12 articles · First reported Apr 01, 2026 · Last updated Apr 01, 2026

Sentiment
10
Attention
2
Articles
12
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The admission of further shares to trading for ProVen VCT and ProVen Growth and Income VCT indicates an increase in their respective share capital, which can slightly dilute existing shareholders but also suggests successful capital raising or dividend reinvestment. This event provides liquidity and transparency for investors on the Aquis Stock Exchange.

Financial services

ProVen VCT and ProVen Growth and Income VCT announced the admission of further ordinary shares to trading on the Aquis Stock Exchange. ProVen VCT admitted 1,131,083 shares on February 6, 2026, under its Dividend Reinvestment Scheme, and an additional 6,464,497 shares on March 18, 2026, from a joint offer for subscription with ProVen Growth and Income VCT. ProVen Growth and Income VCT admitted 1,164,475 shares on February 6, 2026, under its Dividend Reinvestment Scheme, and 5,915,423 shares on March 18, 2026, from the same joint offer. These admissions increase the total number of securities in issue for both companies, with Beringea acting as Company Secretary for these disclosures.

priv
Beringea acts as the Company Secretary for both ProVen VCT and ProVen Growth and Income VCT, handling the administrative aspects of the share admissions.
Importance 20.0 Sentiment 0.0
exch
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.